Literature DB >> 7836696

Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration.

A Giménez1, A Parés, S Alié, J Camps, R Deulofeu, J Caballería, J Rodés.   

Abstract

Collagen synthesis and degradation in normal and carbon-tetrachloride-injured male Wistar rats at early and late stages of liver fibrosis, and the potential beneficial effects of zinc supplementation on liver fibrogenesis and collagenolysis have been assessed by measuring hepatic collagen content and prolyl hydroxylase and collagenase activities. No significant changes in hepatic collagen and prolyl hydroxylase activities were observed between control rats (82 +/- 25 cpm/mg protein) and rats with induced cirrhosis (107 +/- 23 cpm/mg protein) after 4 weeks of carbon tetrachloride injury. By this time, hepatic collagenase activity was significantly lower in rats with induced cirrhosis (61 +/- 9 micro units/mg protein) than in control rats (133 +/- 31 micro units/mg protein) (p < 0.05). This result was prevented by zinc administration, since hepatic collagenase activity was similar in zinc-supplemented, carbon-tetrachloride-injured rats and normal rats (148 +/- 19 micromicrons/mg protein). After 16 weeks, all carbon-tetrachloride-injured rats had cirrhosis. Hepatic collagen content and prolyl hydroxylase activity were significantly higher in carbon-tetrachloride-injured rats than in controls. These effects were partially prevented by zinc administration, since only two of the seven zinc-supplemented, carbon-tetrachloride-injured rats had cirrhosis. Moreover, prolyl hydroxylase activity was significantly lower in zinc-supplemented injured rats (263 +/- 27 cpm/mg protein) than in the non-supplemented respective controls (389 +/- 52 cpm/mg protein) (p < 0.05). No significant changes in hepatic collagenase activity were observed at this stage of liver injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836696     DOI: 10.1016/s0168-8278(05)80304-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats.

Authors:  J Y Wang; Q S Zhang; J S Guo; M Y Hu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.

Authors:  W Keith Jones
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Alcohol-induced myocardial fibrosis in metallothionein-null mice: prevention by zinc supplementation.

Authors:  Lipeng Wang; Zhanxiang Zhou; Jack T Saari; Y James Kang
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C.

Authors:  Takashi Himoto; Hirohito Yoneyama; Akihiro Deguch; Kazutaka Kurokohchi; Michio Inukai; Hisashi Masugata; Fuminori Goda; Shoichi Senda; Seishiro Watanabe; Satoru Kubota; Shigeki Kuriyama; Tsutomu Masaki
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

5.  Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis.

Authors:  Ji-Yao Wang; Jin-Sheng Guo; Chang-Qing Yang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Low Plasma Zinc Is Associated with Higher Mitochondrial Oxidative Stress and Faster Liver Fibrosis Development in the Miami Adult Studies in HIV Cohort.

Authors:  Sabrina S Martinez; Adriana Campa; Yinghui Li; Christina Fleetwood; Tiffanie Stewart; Venkataraghavan Ramamoorthy; Marianna K Baum
Journal:  J Nutr       Date:  2017-02-22       Impact factor: 4.798

7.  Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat.

Authors:  Rosemary Smyth; Michael R Munday; Malcolm J York; Christopher J Clarke; Theo Dare; John A Turton
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

Review 8.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

9.  Tibetan Medical Formula Shi-Wei-Gan-Ning-Pill Protects Against Carbon Tetrachloride-Induced Liver Fibrosis - An NMR-Based Metabolic Profiling.

Authors:  Xin Feng; Ming-Hui Li; Jing Xia; Da J Deng Ba; Ling-Yu Ruan; Yue-Xiao Xing; Cheng Chen; Jun-Song Wang; Ge-Jia Zhong
Journal:  Front Pharmacol       Date:  2018-08-29       Impact factor: 5.810

Review 10.  Zinc and the liver: an active interaction.

Authors:  Ioannis Stamoulis; Grigorios Kouraklis; Stamatios Theocharis
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.487

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.